Penovet

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Penovet

Quick Facts

Property Description
Active ingredient Benzylpenicillin (Penicillin G)
Form Injectable Suspension or Sterile Powder
Pharmacological class Beta-lactam Antibiotic
Common use Systemic Bacterial Infections
Origin Semisynthetic

Penovet's Identity: Definition and Pharmacological Class

Penovet is a prescription-only veterinary medicine whose active component is Benzylpenicillin, internationally recognized as Penicillin G. This core compound is classified within the Beta-lactam antibiotic family, which acts as an antibacterial agent. This class of agents addresses various infections by targeting bacterial structure. Benzylpenicillin is specifically known as a narrow-spectrum antibiotic, a factor differentiating it from broad-spectrum agents, meaning its activity is focused against a specific, limited array of susceptible microorganisms.

Composition, Origin, and Physical Form

Benzylpenicillin is an example of a natural penicillin, though current forms are often considered semisynthetic derivatives. Penovet is a single-agent product that, for clinical use, frequently utilizes salts like Procaine Benzylpenicillin to control the compound’s solubility and ensure a sustained-release effect upon injection. This formulation feature modulates the duration of action. It is typically prepared for parenteral administration—injection into the muscle or under the skin—either as an injectable suspension or a sterile powder for solution. This injectable formulation approach is used for penicillins to optimize absorption kinetics.

General Purpose as a Bactericidal Agent

The overarching purpose of Penovet is to provide a therapeutic intervention against bacterial pathogens by functioning as a bactericidal agent. This means the compound kills bacteria, rather than suppressing their multiplication, by interfering with the process of cell wall synthesis. This mechanism is utilized in veterinary practice for treating acute systemic bacterial infections where rapid microbial elimination is required.

Regulatory References

  1. Beta-lactam Antibiotics
  2. NIH, Clinical Pharmacology
  3. Bactericidal Activity

What side effects are possible with Penovet?

Possible side effects and safety information

The safety profile for Benzylpenicillin (Penicillin G) is formally categorized in regulatory documents, with the primary concern being hypersensitivity reactions. These reactions are officially classified across a spectrum, ranging from common occurrences like skin rash and fever, to very rare but severe events, including anaphylactic shock.

The official labeling notes that adverse reactions are grouped into specific System-Organ Classes, such as those affecting the Nervous System (e.g., risk of convulsions or coma) and the Blood and Lymphatic System (e.g., potential for blood cell abnormalities like granulocytopenia).

Serious and Population-Specific Safety

Serious adverse reactions documented in regulatory sources include Severe Cutaneous Adverse Reactions (SCARs), such as Stevens-Johnson syndrome, and potentially life-threatening Pseudomembranous Colitis.

Specific safety considerations exist for certain populations, including those with renal impairment, where the risk of Central Nervous System (CNS) toxicity is heightened due to delayed excretion. Furthermore, official safety data note that prolonged high-dose use may be associated with the development of blood count abnormalities, which requires regular monitoring of blood counts and renal function.

Treatment is formally contraindicated in individuals with a known history of allergy to penicillins or cross-allergy to other beta-lactam compounds.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory information describes overdose with Penovet (Benzylpenicillin G) primarily through the potential for serious toxicity in the central nervous system and systemic complications. Overdosage is associated with high doses and is more likely to cause severe reactions in patients with compromised kidney function.

Documented Manifestations and Severe Outcomes

Classification Official Regulatory Statement
CNS Toxicity Manifestations include neuromuscular hyperirritability, convulsive seizures, confusion, agitation, asterixis, hallucinations, and eventual coma [1.1, 2.1].
Systemic Risk Severe outcomes include arrhythmias, respiratory failure, and congestive heart failure due to high sodium intake with certain formulations [1.6, 1.7].

Required Emergency Actions

If overdosage is suspected, the regulatory guidance mandates specific actions to protect the patient. The product must be discontinued immediately, and treatment is focused on providing symptomatic and supportive measures [1.7]. No specific antidote is known for Penicillin G overdose.

Immediate medical attention is required in the event of an overdose [1.3]. Emergency services must be contacted without delay if the affected individual has collapsed, had a seizure, has trouble breathing, or cannot be awakened, as stated in the official guidance [2.1].

Therapeutic Uses of Penovet

What Penovet Treats: Main Uses and Benefits

The therapeutic benefit of Penovet is centered on providing supportive relief for acute bacterial infections across various species and organ systems. This product is commonly used in clinical settings that involve acute or unstable symptom patterns affecting the respiratory, reproductive, and urinary systems.

Systemic and Acute Symptom Management

The medication is generally applied in contexts marked by systemic discomfort and noticeable physiological strain, such as those seen in severe conditions like septicemia or shipping fever. Its use is relevant for addressing the underlying bacterial source of the symptoms, which in turn helps ease the overall symptomatic burden and supports the patient during difficult episodes of heightened discomfort. These conditions include bacterial pneumonia, strangles, mastitis, metritis, and specific deep tissue infections like blackleg.

Quick Fact: Relief for Acute Bacterial Symptoms

Property Description
Primary Focus Acute Systemic and Localized Bacterial Infections
Symptom Areas High fever, localized pain/swelling, respiratory distress, lameness
Context of Use Acute episodes of sudden symptom escalation, post-traumatic scenarios
Main Benefit Supports easing the overall symptom load during infectious periods

Eligibility and Restrictions for Use

Who Can and Cannot Use Penovet?

The population eligibility for Penovet (Procaine Benzylpenicillin), a veterinary medicine, is determined by the target species, physiological status, and regulatory safety constraints, as outlined in official government labeling.

Absolute Prohibitions

Penovet is contraindicated and must not be used in animals with a confirmed hypersensitivity or allergy to Penicillins, other beta-Lactam antibiotics, or the procaine component. Furthermore, use is strictly prohibited in certain small herbivorous mammals, including guinea pigs, hamsters, and gerbils, due to the high risk of fatal enterotoxemia.

Eligible and Restricted Populations

Penovet is labeled for use in target species including cattle, pigs, and sheep. Use in horses is generally permitted only if they are not intended for the human food chain. Use in food-producing animals (cattle, sheep, pigs) is subject to strict mandatory withdrawal periods for meat and milk before these products can enter the food supply, as mandated by regulatory authorities. The medicine requires caution when used in animals with impaired renal (kidney) function or pre-existing serious cardiac rhythm disturbances, and specific caution is advised for very young piglets.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Benzylpenicillin (Penovet's active ingredient) is largely defined by its elimination pathway and specific pharmacodynamic effects, as documented in official regulatory sources. The most significant interactions involve substances that compete with Benzylpenicillin for renal tubular secretion. Co-administration of medicines like Probenecid and certain Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), such as Phenylbutazone and high-dose Aspirin, can competitively inhibit the kidney's active transport system, which is the primary route for Penicillin G clearance. This mechanism results in the official outcome of increased and prolonged Benzylpenicillin serum concentrations.

Pharmacodynamic Conflicts and Administration Restrictions

Official labeling advises against the concurrent use of Benzylpenicillin with bacteriostatic antibiotics, including drugs from the Tetracycline class. This is based on a documented risk of pharmacodynamic antagonism, where the bacteriostatic action may interfere with the bactericidal activity of penicillin. Furthermore, Benzylpenicillin may enhance the effect of anticoagulants, which necessitates monitoring when combined. A documented interaction exists where penicillin may reduce the effectiveness of hormonal contraceptives.

Population-specific considerations mandate caution in patients with renal impairment, as reduced clearance leads to drug accumulation and an increased risk of toxicity, a fact explicitly noted in regulatory prescribing information.

Mechanism of Action

How Penovet Works: Mechanism of Action

The mechanism of Benzylpenicillin (Penicillin G) is focused entirely on the selective destruction of the bacterial cell structure, driven by its molecular interaction with bacterial enzymes.


Irreversible Blockade of Cell Wall Construction

The drug's action begins by targeting bacterial enzymes called Penicillin-Binding Proteins (PBPs), specifically the D,D-transpeptidases, which mediate the final formation of the bacteria's rigid outer shell. Benzylpenicillin acts as a substrate mimic and binds to these enzymes, forming an irreversible covalent bond that permanently inactivates them. This highly specific molecular block arrests the final cross-linking step of the bacteria's peptidoglycan synthesis pathway.


Triggering of Fatal Osmotic Lysis

The physiological consequence of blocking cell wall construction is the creation of a structurally defective outer layer. This weak structure is unable to resist the massive internal turgor pressure exerted by the bacterial cytoplasm. This pressure imbalance forces the cell membrane to rupture, a process known as osmotic lysis, which constitutes the bactericidal activity of the compound. The mechanism is most effective during the bacterial active multiplication phase, as the cells are actively synthesizing new cell wall components.

Dosage and Administration Information

How to Use Penovet

Penovet, which contains the active ingredient Benzylpenicillin, is administered via specific routes, dosages, and durations. This medicine is a prescription-only veterinary product, and its usage is structured around precise quantitative parameters.


Administration Routes and Technique

The standard routes of delivery for the sustained-release suspension are Intramuscular (IM) or Subcutaneous (SC) injection. For rapidly-acting salts, such as Benzylpenicillin Sodium, the Slowly Intravenous (IV) route is also authorized. When administering any injectable preparation, proper procedural steps are required; for example, aspiration must be performed before executing an intramuscular injection.


Official Dosing and Frequency

Dosage is determined by the recipient's accurate body weight, with minimum thresholds established across different species for the Procaine Benzylpenicillin suspension.

Species Minimum Labeled Dose Frequency
Cattle and Pigs ge 10 mg/kg body weight Once every 24 hours
Horses ge 12 mg/kg body weight Once every 24 hours
Dogs and Cats ge 20 mg/kg body weight Once every 24 hours

The treatment course duration is at least three days, with a maximum period of seven consecutive days.


Procedural Constraints

The volume administered at any single injection site must not exceed 5 ml for depot preparations; larger calculated doses must be divided and administered into multiple sites. Furthermore, a constraint against chemical incompatibility requires that the product must not be mixed with other pharmaceutical products in the same syringe.

Recent Clinical Evidence

Research evidence / Overview of Studies for Penovet

Evidence for Use in Acute Systemic and Localized Bacterial Infections

The research base for Benzylpenicillin (Penovet) largely derives from decades of regulatory evaluation and clinical study, in which the medicine was evaluated. This includes various research types that have been used in research exploring how symptoms change over time in the setting of bacterial infections across different animal species.

Studies explored the use of Benzylpenicillin in conditions associated with acute or disruptive episodes. Researchers utilized both Randomized Controlled Trials (RCTs), where the medicine was compared against other protocols, and large-scale observational studies in diseased populations. The outcomes research examined focused primarily on microbial status (whether the causative bacteria were cleared) and clinical outcomes related to physical discomfort (changes in visible symptoms like fever or localized swelling) over defined time intervals.

Regulatory reviews from bodies like the European Medicines Agency have utilized this cumulative evidence base to describe the patterns observed in the studies and establish the current understanding of the medicine’s role. These findings describe patterns observed in the studies related to its use against known susceptible bacteria.


Types of Studies Supporting the Research Record

Research describes how the drug is absorbed and distributed, providing estimations of drug concentrations in the body, primarily through Pharmacokinetic/Pharmacodynamic (PK/PD) studies. This foundational research is supplemented by RCTs which were applied in studies examining short-term or episodic symptom patterns and comparing Benzylpenicillin against other types of therapeutic protocols. This comprehensive body of evidence contributes to the broader research landscape for Benzylpenicillin.


What is Still Uncertain and Research Gaps

Evidence quality varies across studies, largely due to differences in design and the age of the research. Comparative evidence is lacking for certain new treatment protocols, meaning that few recent, large-scale RCTs have explored direct comparisons of Benzylpenicillin against every modern broad-spectrum alternative.

Furthermore, long-term effects are not fully established for the durability of response. Finally, because bacterial resistance can evolve, Studies monitor the in vitro susceptibility of pathogens and the data show patterns related to susceptibility in different regions and populations.

Key Studies & References

  1. A Pilot Study in Sweden on Efficacy of Benzylpenicillin, Oxytetracycline, and Florfenicol in Treatment of Acute Undifferentiated Respiratory Disease in Calves (BRD Trial)

Frequently Asked Questions (FAQ)

Common questions about Penovet (FAQ)


Q: How quickly does Penovet start working after the first dose?

Official information describes the absorption rate of the active ingredient, Benzylpenicillin. After an intramuscular injection, the concentration of the medicine often reaches its peak in the body within about 30 minutes. Following a subcutaneous injection, the peak level is typically observed around two hours after administration. This pharmacological data indicates when the active substance is expected to reach its highest concentration in the bloodstream.


Q: How long can I expect to take Penovet for the condition it is treating?

Regulatory texts establish the typical duration for the prescribed course. The medicine is often used for a minimum course of three days and a maximum of seven consecutive days. The precise length is determined by the prescribing professional, following established guidelines for duration, which help manage the infection and minimize the potential for bacterial resistance.


Q: What should I do if I forget to take a dose of Penovet?

According to official product information, if a dose is missed, regulatory documents generally advise that you contact the professional responsible for the treatment (the veterinarian) for guidance regarding the next steps. This consultation is necessary to ensure the continuity of the treatment plan.


Q: Is Penovet safe for use in older adult patients?

Official labeling for related medicines containing Benzylpenicillin notes that older individuals (analogous to older animals in veterinary medicine) may require extra monitoring. Because kidney function, which clears the drug from the body, can be reduced, official information suggests that monitoring or dosage adjustment may be required to manage the risk of drug accumulation.


Q: Can Penovet be used by people with a history of liver problems?

While the active ingredient, Benzylpenicillin, is generally considered to have a low risk of causing liver injury, some official resources suggest caution. If a history of liver problems exists, official resources indicate that monitoring or adjustment to the therapeutic plan may be advised.


Q: Are there any known long-term effects associated with using Penovet?

Official documents note that when the medicine is used for a prolonged duration, there are potential associated effects. These include the possibility of overgrowth of non-sensitive organisms (like yeast or fungi). For such use, official documents indicate that regular blood tests and monitoring of the blood system may be advised.


Q: Does Penovet affect the ability to drive or operate machinery?

The official safety profile reports possible nervous system side effects that might affect normal functions. These reactions can include feelings of dizziness, somnolence (sleepiness), confusion, and, in rare instances, seizures. If such effects are noted, they may indicate a change in the animal's normal coordination or function.


Q: Can Penovet cause changes in mood or sleep patterns?

The medicine's effects on the nervous system can extend beyond physical symptoms. Regulatory documents list possible adverse effects such as somnolence (sleepiness), anxiety, agitation, and nervousness (which can impact mood), as well as confusion.


Q: Is Penovet available in different forms (tablet, liquid, injection, etc.)?

The active ingredient, Benzylpenicillin, is most commonly described in regulatory documents for parenteral administration (by injection). It is prepared either as an injectable suspension or as a sterile powder to be mixed into a solution before injection. While related types of penicillin may be described in other forms, Penovet is typically used in the injectable format.


Q: Does the effectiveness of Penovet change if taken with or without food?

Penovet is formulated for administration via injection, meaning it bypasses the digestive system entirely. Official pharmacological data indicates that if the medicine were taken orally, its absorption would be poor and easily degraded by stomach acid. Therefore, its effectiveness is not linked to food consumption.


Q: What should I do if a less common side effect appears while on Penovet?

Official product information is clear that certain symptoms require professional attention. If serious but less common reactions like a widespread skin rash, swelling of the lips, or difficulty breathing (signs of an allergic reaction) appear, official documents advise seeking prompt medical care from the prescribing professional immediately.


Q: Can Penovet be taken in combination with aspirin or ibuprofen?

Official information on interactions states that combining Benzylpenicillin with Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), a class that includes both aspirin and ibuprofen, can affect the way the body handles the medicine. The official result of this combination is an increase and prolongation of the Benzylpenicillin levels in the body due to a competitive effect in the kidneys.


Q: What is the typical duration of Penovet's effect on the body?

The duration of effect depends on the specific formulation being used. For the long-acting suspensions, regulatory documents describe that effective drug concentrations may be maintained in the body for up to 4 to 5 days following a single dose. This extended duration of action is a design feature of these specific preparations.


Q: What happens if I stop taking Penovet suddenly?

Official warnings state that prematurely stopping the medication before the full course is complete is strongly discouraged. Untimely termination may lead to the failure to clear the infection entirely and may support the development of resistant bacterial strains. Regulatory warnings state that termination of treatment should be discussed with and agreed upon by the prescribing professional.


Q: Is it normal to feel a specific sensation when first starting Penovet?

Official documents describe the possibility of a temporary body reaction called a Jarisch-Herxheimer reaction in some instances. This is a known response to the mass killing of bacteria and can cause temporary symptoms like fever, chills, headache, and tiredness shortly after starting the medicine.


Q: Can I take Penovet if I am already taking over-the-counter pain relievers?

The active ingredient can interact with certain pain relievers, specifically those in the NSAID class like ibuprofen and aspirin, causing an increase in the Benzylpenicillin levels in the body. For over-the-counter products, it is advised to discuss all potential interactions with the prescribing professional before use to manage the risk of increased concentration.


Q: Does Penovet interact with common foods or supplements like vitamins?

Official regulatory documents primarily focus on interactions with other prescription and over-the-counter medicines. There are no specific warnings in official labeling regarding general interactions between Penovet's injectable formulation and common foods or routine vitamin supplements.


Q: Is it required to have routine lab tests while taking Penovet?

Regulatory safety information indicates that routine lab tests are advised in specific situations. Patients receiving a prolonged course of high-dose therapy may require regular monitoring of their blood counts and kidney function to ensure safety.


Q: Can Penovet affect the results of any common medical tests?

The potential for the active ingredient to cause blood count abnormalities, such as granulocytopenia, is noted in the official safety data. This means that lab tests designed to measure blood counts may show results affected by the medicine. You may wish to inform the testing professional that Penovet is being used.


Q: How is the safety profile of Penovet generally described in official sources?

The official safety profile is described by regulatory bodies with the primary concern being the risk of hypersensitivity reactions (allergies), which can range from minor rashes to severe, rare events. The documents also categorize potential adverse effects into system classes, such as those affecting the nervous system (like convulsions) and the blood and lymphatic system.


Q: Are there any common misconceptions about how Penovet works?

The core function of Penovet is to kill bacteria (bactericidal), which is achieved by targeting the specific enzymes necessary to build the bacterial cell wall. A key point of clarification is that its effectiveness is dependent on the bacteria actively growing, and it does not work by simply suppressing bacterial multiplication.

How should Penovet be stored and disposed of?

How to Store and Dispose of Penovet?

Official regulatory documents define strict storage and disposal requirements for Penovet (Procaine Benzylpenicillin injectable suspension) to maintain its stability.


️ Storage Conditions

The product must be stored in a refrigerator at temperatures between 2 C and 8 C. It is explicitly required that the suspension must not be frozen and must be kept protected from light. Penovet must be stored in its original container and kept out of the sight and reach of children.


⏳ Stability and Disposal

After the first puncture of the container, the in-use shelf-life is typically 28 days, provided the container is continuously stored in the refrigerator. Unused or expired Penovet and waste materials must be disposed of strictly in accordance with local/national regulatory requirements. The product should not be discarded into conventional wastewater or domestic household refuse.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Penovet found in:

A-Z Index: